Literature DB >> 18174027

Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease.

Ying Liu1, Fei Liu, Khalid Iqbal, Inge Grundke-Iqbal, Cheng-Xin Gong.   

Abstract

Brain glucose uptake/metabolism is impaired in Alzheimer disease (AD). Here, we report that levels of the two major brain glucose transporters (GLUT1 and GLUT3) responsible for glucose uptake into neurons were decreased in AD brain. This decrease correlated to the decrease in O-GlcNAcylation, to the hyperphosphorylation of tau, and to the density of neurofibrillary tangles in human brains. We also found down-regulation of hypoxia-inducible factor 1, a major regulator of GLUT1 and GLUT3, in AD brain. These studies provide a possible mechanism by which GLUT1 and GLUT3 deficiency could cause impaired brain glucose uptake/metabolism and contribute to neurodegeneration via down-regulation of O-GlcNAcylation and hyperphosphorylation of tau in AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174027      PMCID: PMC2247364          DOI: 10.1016/j.febslet.2007.12.035

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  30 in total

1.  Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease.

Authors:  Marcus Rössler; Rosemarie Zarski; Jürgen Bohl; Thomas G Ohm
Journal:  Acta Neuropathol       Date:  2001-12-21       Impact factor: 17.088

Review 2.  Expression, regulation, and functional role of glucose transporters (GLUTs) in brain.

Authors:  Donard S Dwyer; Susan J Vannucci; Ian A Simpson
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

3.  Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5.

Authors:  F Liu; T Zaidi; K Iqbal; I Grundke-Iqbal; C-X Gong
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 4.  Glucose transporter expression in the central nervous system: relationship to synaptic function.

Authors:  Bruce S McEwen; Lawrence P Reagan
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

Review 5.  Signal transduction cascades associated with oxidative stress in Alzheimer's disease.

Authors:  Robert B Petersen; Akihiko Nunomura; Hyoung-gon Lee; Gemma Casadesus; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2007-05       Impact factor: 4.472

6.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia.

Authors:  C Chen; N Pore; A Behrooz; F Ismail-Beigi; A Maity
Journal:  J Biol Chem       Date:  2000-12-18       Impact factor: 5.157

Review 8.  Postnatal development of calcium-binding proteins immunoreactivity (parvalbumin, calbindin, calretinin) in the human entorhinal cortex.

Authors:  L Grateron; S Cebada-Sanchez; P Marcos; A Mohedano-Moriano; A M Insausti; M Muñoz; M M Arroyo-Jimenez; A Martinez-Marcos; E Artacho-Perula; X Blaizot; R Insausti
Journal:  J Chem Neuroanat       Date:  2003-12       Impact factor: 3.052

9.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; William R Markesbery
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

Review 10.  Signal transduction to hypoxia-inducible factor 1.

Authors:  Gregg Semenza
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

View more
  122 in total

Review 1.  Metabolic reserve as a determinant of cognitive aging.

Authors:  Alexis M Stranahan; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

Review 3.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

4.  Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice.

Authors:  Yanxing Chen; Zhihou Liang; Zhu Tian; Julie Blanchard; Chun-Ling Dai; Sonia Chalbot; Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Mol Neurobiol       Date:  2013-08-31       Impact factor: 5.590

Review 5.  Brain fuel metabolism, aging, and Alzheimer's disease.

Authors:  Stephen Cunnane; Scott Nugent; Maggie Roy; Alexandre Courchesne-Loyer; Etienne Croteau; Sébastien Tremblay; Alex Castellano; Fabien Pifferi; Christian Bocti; Nancy Paquet; Hadi Begdouri; M'hamed Bentourkia; Eric Turcotte; Michèle Allard; Pascale Barberger-Gateau; Tamas Fulop; Stanley I Rapoport
Journal:  Nutrition       Date:  2010-10-29       Impact factor: 4.008

6.  Metabolism of galactose in the brain and liver of rats and its conversion into glutamate and other amino acids.

Authors:  Martin Roser; Djuro Josic; Maria Kontou; Kurt Mosetter; Peter Maurer; Werner Reutter
Journal:  J Neural Transm (Vienna)       Date:  2008-12-17       Impact factor: 3.575

7.  Dissociable effects of advanced age on prefrontal cortical and medial temporal lobe ensemble activity.

Authors:  Abbi R Hernandez; Jordan E Reasor; Leah M Truckenbrod; Keila T Campos; Quinten P Federico; Kaeli E Fertal; Katelyn N Lubke; Sarah A Johnson; Benjamin J Clark; Andrew P Maurer; Sara N Burke
Journal:  Neurobiol Aging       Date:  2018-06-30       Impact factor: 4.673

8.  GLUT3 gene expression is critical for embryonic growth, brain development and survival.

Authors:  Mary O Carayannopoulos; Fuxia Xiong; Penny Jensen; Yesenia Rios-Galdamez; Haigen Huang; Shuo Lin; Sherin U Devaskar
Journal:  Mol Genet Metab       Date:  2014-01-31       Impact factor: 4.797

9.  Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer's disease with aging.

Authors:  Masatoshi Tomi; Yuanzi Zhao; Shanthie Thamotharan; Bo-Chul Shin; Sherin U Devaskar
Journal:  Brain Res       Date:  2012-12-07       Impact factor: 3.252

Review 10.  Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.

Authors:  C-X Gong; K Iqbal
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.